Alcidion Group Limited · ASX:ALC

Alcidion — Shareholder Meeting (November 2021)

13 slides from Alcidion's shareholder meeting presentation, Nov 17, 2021

  1. Slide 1: Group Managing Director Report

    For personal use only Group Managing Director Report Kate Quirke Group Managing Director | CEO COMMERCIAL IN CONFIDENCE 1

  2. Slide 2: Case Studies

    Case Studies For personal use only • Miya Precision to support virtual care • Pilot project in ED clinical decision support • First deployment of Better Meds in delivered by rpavirtual with mobile EMR, Miya Memory southern hemisphere • Initial focus COVID care; extended to all • Extended to support

  3. Slide 3: Evolving Models - Virtual Care & Remote Monitoring

    Evolving Models - Virtual Care & Remote Monitoring For personal use only • Virtual care & remote patient monitoring (RPM) have long been recognised to deliver benefits in management of chronic & post acute care patients • COVID accelerated digitally enabled models of care • Virtual care has been sho

  4. Slide 4: Our People

    Our People For personal use only • We invested in our people in FY21 which was critical to our success & ability to deliver on our plan • We grew by 23% across corporate, sales & marketing, services & product • We established a People, Place & Culture team to address an increasingly diverse & geogra

  5. Slide 5: United Kingdom Update

    For personal use only United Kingdom Update Lynette Ousby UK Managing Director COMMERCIAL IN CONFIDENCE 5

  6. Slide 6: 2021 – A Year of Achievement

    2021 – A Year of Achievement For personal use only NHS Lanarkshire New client  Patientrack Isle of Man – Manx Care South Tees Hospitals NHS Existing Patientrack client Foundation Trust  Smartpage New client  Miya Precision  Patientrack East Lancashire Hospitals  Smartpage NHS Trust  Better Med

  7. Slide 7: Case Studies

    Case Studies For personal use only • First UK Miya Precision • First meeting in March 2020; procurement live in 2021 contract signed eight months later in November 2020 • Subsequent procurement of Miya Memory (mobile EPR) • 100% cloud deployed go-live in November 2021 • Bespoke extension to manage d

  8. Slide 8: Acceleration of Digital Strategy

    Acceleration of Digital Strategy For personal use only • Chancellor Rishi Sunak confirmed £2.1billion for NHS IT upgrades & digital health technology in budget released October 27 Core Pillars of Digital Strategy (EPR Strategy) – Funding will cover “innovative use of digital technology so hospitals

  9. Slide 9: Acquisition of ExtraMed

    Acquisition of ExtraMed For personal use only Long-standing UK market leader in patient flow, addressing key pain-points for hospital administrative staff Business Overview Value Proposition • Leading UK provider with 20+ year track record providing patient flow management software • 9 long-standing

  10. Slide 10: Salford – opportunity to partner with Hitachi

    Should be ok Salford – opportunity to partner with Hitachi For personal use only Building the UK’s first ‘Digital Control Centre’, a fully integrated digital transformation of care processes • ExtraMed awarded sub-contract for patient flow management as part of £25m large-scale IT project with lead

  11. Slide 11: UK Growth Strategy

    UK Growth Strategy For personal use only Accelerating sales in the UK as part of becoming a leading global healthcare technology organisation 1 Upsell Miya Precision (or other modules) to existing Alcidion customers 2 Win new Miya Precision clients 3 List on Procurement Frameworks (to leverage Digit

  12. Slide 12: Growth Strategy

    Growth Strategy For personal use only Accelerating sales to become a leading global healthcare technology organisation 1 Upsell Miya Precision (or other modules) to existing Alcidion customers 2 Win new Miya Precision clients 3 Continue to forge strong relationships with our customers 4 Strategic Ac

  13. Slide 13: For personal use only

    For personal use only COMMERCIAL IN CONFIDENCE 13

Alcidion Group — Shareholder Meeting (November 2021) on 6ix